SAS | The Power to Know
cq5dam.thumbnail.319.319
White Paper

Customer Intimacy: The Pharma Challenge

Industry leaders weigh in on how pharmaceutical companies can become more relevant to their trifecta of customers, physicians, payers and patients

About this paper

Up until recently, pharmaceutical companies largely followed a product-centric marketing model. However, growing threats to profitability -- such as increasing generic competition, weak new product pipelines, leaner margins, new regulatory and payer pressures, and less access to physicians -- are compelling the industry to change to a more customer-centric business model. In a recent webcast co-sponsored by Pharmaceutical Executive and SAS, experts discussed nuances and best practices around the idea of a customer-focused marketing environment, starting with a data infrastructure that provides deeper customer insights, then analyzing the data to deliver more relevant information and messaging, which in turn drives customer engagement and deeper relationships. This paper summarizes the highlights of that webcast.

Über SAS

SAS ist weltweit Marktführer im Bereich Analytics und mit 3,16 Milliarden US-Dollar Umsatz einer der größten Softwarehersteller. Kunden an mehr als 80.000 Standorten setzen innovative Analytics-, Business-Intelligence- und Datenmanagement-Software und -Services von SAS ein, um schneller bessere Geschäftsentscheidungen zu treffen. Seit 1976 verschafft SAS Kunden rund um den Globus THE POWER TO KNOW.

Firmensitz der US-amerikanischen Muttergesellschaft ist Cary, North Carolina. SAS Switzerland hat seine Zentrale in Zürich und eine weitere Niederlassung in Genf. Weitere Informationen über SAS.

Sie haben bereits ein SAS Profil? Um das Formular automatisch auszufüllen, hier anmelden: Einloggen

*
*
*
*
 
*
*
 
 

Back to Top